Search for: "Federal, Inc."
Results 101 - 120
of 57,664
Sorted by Relevance
|
Sort by Date
15 Sep 2011, 9:59 pm
Noonan -- The Federal Circuit reaffirmed the primacy of the factual disclosures used to establish obviousness, and how deficiencies thereof can defeat an obviousness claim, in reversing an invalidity determination in Star Scientific, Inc. v. [read post]
7 Oct 2008, 11:42 pm
The Federal Circuit’s recent decision in Muniauction, Inc. v. [read post]
11 Jun 2023, 8:17 pm
Noonan -- In its recent review of a district court decision the Federal Circuit characterized as "a thorough opinion," the Federal Circuit affirmed invalidation for obviousness of four claims from four different Orange Book-listed patents in Vanda Pharmaceuticals Inc. v. [read post]
11 Nov 2018, 9:59 pm
Noonan -- On Friday, the Federal Circuit handed down its decision in Arista Networks, Inc. v. [read post]
26 Aug 2021, 7:34 pm
Both these examples of "from many, one" come to mind when considering the Federal Circuit's opinion today in Juno Therapeutics, Inc. v. [read post]
14 Apr 2014, 9:59 pm
By Michael Greenfield -- Last Friday, the Federal Circuit issued an opinion in Hoffman La-Roche Inc. v. [read post]
21 Dec 2020, 9:03 pm
Maia Pharmaceuticals, Inc. [read post]
3 Dec 2014, 9:59 pm
Noonan -- That it is more difficult today to be a patentee able to defend her patent rights than any time since the 1940's is nicely illustrated by the Federal Circuit's decision in Par Pharmaceutical, Inc. v. [read post]
27 Nov 2019, 8:51 pm
Lifescan, Inc. involved Pharma Tech's assertion of U.S. [read post]
28 Nov 2016, 9:59 pm
In a recent nonprecedential opinion, the Federal Circuit illustrated the consequences when these efforts prove inadequate, in Roxane Labs., Inc. v. [read post]
8 May 2017, 8:27 pm
Noonan -- The Federal Circuit's decision on Friday, in Braintree Laboratories, Inc. v. [read post]
19 Jan 2020, 9:58 pm
By Donald Zuhn –- Last week, the Federal Circuit issued a per curiam Order in BioDelivery Sciences International, Inc. v. [read post]
5 May 2011, 9:59 pm
Associated Regional and University Pathologists, Inc., the Federal Circuit determined that the District Court for the Central District of California had properly granted summary judgment of invalidity with respect to U.S. [read post]
11 Aug 2017, 8:00 am
Amgen, Inc. [read post]
26 Sep 2013, 9:33 pm
By Andrew Williams -- Saying "But I won't do it" is not sufficient to avoid infringement in a Hatch-Waxman litigation, according to the Federal Circuit in the recently decided Sunovion Pharmaceuticals, Inc. v. [read post]
7 Dec 2015, 4:13 pm
News release: “The Federal Trade Commission today filed an administrative complaint charging that Staples, Inc. [read post]
1 Dec 2023, 6:00 am
Sweet Nothings, Inc. and Beth Porter have initiated a Motion to Dismiss based on lack of personal jurisdiction under Federal Rule of Civil Procedure 12(b)(2) and failure to state a claim under Rule 12(b)(6). [read post]
13 May 2010, 9:34 pm
On April 28, the Court of Appeals for the Federal Circuit granted the petition for rehearing en banc submitted by Plaintiffs-Appellants Abbott Diabetes Care, Inc. [read post]
24 Nov 2014, 12:18 pm
In a recent decision, Versata Software, Inc. v. [read post]
16 Aug 2020, 9:41 pm
Ultimately, the Federal Circuit affirmed the Board's findings holding the patents invalid. [read post]